HKSE - Delayed Quote HKD
Laekna, Inc. (2105.HK)
At close: 3:59 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-295,603.000
-295,603.000
-306,283.000
-198,007.000
Investing Cash Flow
-323,161.000
-323,161.000
-4,220.000
-8,712.000
Financing Cash Flow
735,974.000
735,974.000
312,580.000
412,414.000
End Cash Position
440,815.000
440,815.000
323,070.000
296,412.000
Capital Expenditure
-1,313.000
-1,313.000
-5,085.000
-9,121.000
Issuance of Capital Stock
709,794.000
709,794.000
301,082.000
412,538.000
Issuance of Debt
54,400.000
54,400.000
19,650.000
2,000.000
Repayment of Debt
-24,960.000
-24,960.000
-2,000.000
--
Repurchase of Capital Stock
--
--
-5,029.000
--
Free Cash Flow
-296,916.000
-296,916.000
-311,368.000
-207,128.000
12/31/2021 - 6/29/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1541.HK IMMUNEONCO-B
7.590
-2.32%
1952.HK Everest Medicines Limited
33.450
-0.15%
6660.HK AIM Vaccine Co., Ltd.
8.280
-1.43%
1228.HK CANBRIDGE-B
0.260
+7.88%
1477.HK OCUMENSION-B
5.470
+1.67%
1873.HK VIVA BIOTECH
0.990
+4.21%
ANL Adlai Nortye Ltd.
2.0300
+0.50%
2616.HK CStone Pharmaceuticals
1.970
-3.90%
6990.HK Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
184.000
+0.11%
2171.HK CARsgen Therapeutics Holdings Limited
4.820
+1.47%